Bilcare

Bilcare Gross Margin

The Gross Margin of Bilcare (526853.BO) as of Nov 3, 2026 is 22.39 %. In the previous year, Gross Margin was 31.61 % — a change of -29.19% (lower).

Gross Margin

22.39 %

YoY

-29.19%

Last updated:

Gross Margin of Bilcare is 2026 22.39 % . Gross Margin of Bilcare was 2025 31.61 % . It decreases by -29.19% lower compared to the previous year.

Bilcare's gross margin stands at 22.4%, down from 29.1% several years earlier.

The Bilcare Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
45.35 INR
Jan 1, 2020
45.18 INR
Jan 1, 2021
34.33 INR
Jan 1, 2022
29.10 INR
Jan 1, 2023
22.07 INR
Jan 1, 2024
32.25 INR
Jan 1, 2025
31.61 INR
Jan 1, 2026
22.39 INR
The Bilcare Gross Margin history
YEARGross MarginYoY
22.39 %-29.19%
31.61 %-1.97%
32.25 %+46.10%
22.07 %-24.15%
29.10 %-15.23%
34.33 %-24.02%
45.18 %-0.38%
45.35 %+0.24%
45.24 %+0.73%
44.92 %-5.11%
47.34 %+4.26%
45.40 %+21.31%
37.43 %+11,542.80%
0.32 %-7.61%
0.35 %-16.59%
0.42 %-4.04%
0.43 %-0.86%
0.44 %-6.69%
0.47 %+9.61%
0.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bilcare Stock analysis

What does Bilcare do? Bilcare Ltd. provides pharma packaging research solutions through specialty polymer films and aluminum foils for solid-dosage pharmaceutical products. The company offers global clinical services, R&D services, and anti-counterfeit technology (nCid) as part of its product portfolio. Bilcare handles domestic and global manufacturing of investigational medicinal products (IMPs) and placebos, including primary and secondary packaging with blinding techniques, interactive Web response systems (IWRS), and temperature-controlled storage. Its clients include pharmaceutical companies requiring packaging solutions, clinical trial support, and anti-counterfeit measures for their products. The firm operates manufacturing facilities in Pune, India, with global depots spread across approximately 30+ locations worldwide. Bilcare's services target pharmaceutical manufacturers seeking packaging innovation, clinical trial management, and secure product authentication. The company leverages its presence in India, Singapore, Germany, and the United States to serve international clients needing comprehensive packaging and clinical services. Bilcare's revenue streams come from the sale of specialty polymer films, aluminum foils, and anti-counterfeit technology (nCid). The company also generates income through manufacturing IMPs and placebos, packaging services, and clinical trial support including IWRS and temperature-controlled storage. Clients primarily consist of pharmaceutical firms requiring end-to-end packaging solutions and secure clinical trial execution. Bilcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bilcare stock

Gross Margin of Bilcare is 22.39 % in 2026.

Gross Margin of Bilcare changed from 31.61 % to 22.39 %, representing a -29.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Bilcare since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Bilcare with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bilcare

All Key Metrics — Bilcare